Silex Systems SEC Filings

Type
Report
Date
No documents available

Silex Systems Documents 2026

This page contains all official documents and SEC filings for Silex Systems stock (SLX.AX, ISIN: AU000000SLX4). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of Silex Systems's regulatory filings.

Silex Systems Stock analysis

Silex Systems Silex Systems Ltd is an Australian technology company specializing in the development and application of laser isotope separation technologies. It was founded in 1985 and is based in Sydney. The company initially focused on developing laser isotope separation technologies for the defense industry. In the 1990s, it shifted its focus to the development of separation processes for uranium isotopes for energy generation. Silex Systems acquired the rights to uranium isotope separation technology from the Australian government atomic agency in 2006 and has since become a leading provider of uranium isotope separation technologies globally. The company's business model involves developing, licensing, and marketing technologies for isotope separation of uranium. It operates in the energy generation and nuclear industry sectors, working on improving the energy efficiency of nuclear power plants and developing technologies for safety monitoring and waste separation. Silex Systems' main divisions are nuclear and weapon technology and energy generation. The company offers various products based on laser isotope separation technology, including the SILEX technology for uranium isotope separation, laser-induced breakdown spectroscopy (LIBS), and proportional gas counters for monitoring radioactive gases in the nuclear industry.